导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 20.04% | 201/1050 |
| 近一周 | -3.92% | 968/1104 |
| 近一月 | -7.65% | 884/1102 |
| 近一季 | -15.53% | 847/1092 |
| 近半年 | 7.66% | 280/1070 |
| 近一年 | 22.72% | 213/1018 |
| 近两年 | 85.99% | 243/926 |
| 近三年 | 55.55% | 222/834 |
| 成立以来 | 344.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.56% 288/1070 |
64.86% 161/1101 |
- - |
- - |
| 2025 | 35.12% 393/1065 |
10.82% 132/1014 |
-2.97% 893/1038 |
25.34% 436/1050 |
0.25% 439/1065 |
| 2024 | 0.27% 573/1011 |
-1.91% 416/960 |
-0.24% 321/983 |
7.51% 799/991 |
-4.69% 650/1011 |
| 2023 | -14.36% 496/952 |
3.18% 435/880 |
-5.54% 560/895 |
-8.70% 538/915 |
-3.77% 389/952 |
| 2022 | -8.41% 66/867 |
-9.50% 91/773 |
16.99% 70/806 |
-3.18% 38/845 |
-10.65% 800/867 |
| 2021 | 55.03% 8/740 |
-2.40% 239/580 |
21.49% 139/659 |
15.77% 33/704 |
12.93% 38/740 |
| 2020 | 65.21% 164/554 |
-0.48% 172/419 |
22.66% 233/466 |
14.67% 148/517 |
18.02% 155/554 |
| 2019 | 32.28% 277/410 |
29.02% 427/1149 |
-6.80% 837/1231 |
1.35% 297/390 |
8.53% 218/410 |
| 2018 | -26.80% 173/349 |
- - |
- - |
- - |
-9.27% 242/1080 |
| 2017 | 15.17% 102/285 |
- - |
- - |
- - |
- - |
| 2016 | -7.21% 56/205 |
- - |
- - |
- - |
- - |
| 2015 | 23.93% 52/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 建信潜力新蓝筹股票A VS. 东吴新产业精选股票A(580008) |